Reagents.
Ended Awarded
- Contract number
- HT009026FG1130039
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $10,716
Award facts
- Contract value 100% obligated
- $10,715.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation for reagents, with a ceiling value of $10,715.94. This is a child contract under a larger indefinite delivery vehicle, representing a single delivery order against an existing BPA. The award, made on November 14, 2025, carries an ultimate completion date of September 30, 2026, with performance taking place at Roche's facility in Castleton, Indiana. No set-aside designation was used for this procurement, indicating open competition in the federal marketplace.
Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, is a principal supplier of diagnostic solutions to the Defense Health Agency and Department of Veterans Affairs. The company specializes in in vitro diagnostics, laboratory instruments, reagents, and associated medical products, including molecular diagnostic analyzers, immunochemistry testing platforms, histology staining systems, and point-of-care testing devices. This BPA call for reagents aligns with the Defense Health Agency's broader clinical laboratory operations and supports the organization's diagnostic testing capabilities across military and federal healthcare facilities. The company maintains multiple active contract vehicles with the Defense Health Agency valued in the millions of dollars, reflecting sustained demand for its comprehensive diagnostic portfolio through 2030.
Quick answers
Who was awarded contract HT009026FG1130039?
HT009026FG1130039 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on November 14, 2025.
How much is contract HT009026FG1130039 worth?
The government has obligated $10,716 on HT009026FG1130039.
Is contract HT009026FG1130039 an order under another contract?
Yes. HT009026FG1130039 is a BPA call under FA301625A0005, a blanket purchase agreement.
Was contract HT009026FG1130039 competed?
The extent of competition for HT009026FG1130039 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award